For Research Purposes Only — This compound is not FDA approved.

Catalog
BPC-157
Tissue Repair Research

BPC-157

A synthetic pentadecapeptide studied for cellular-repair and angiogenesis signaling in research models. Premium Research Peptide.

Amount
Quantity
1
Bundle & Save
Only 42 left in stock 18 people viewing now
Est. delivery in 2–5 business days
Free shipment protection
Overnight shipping available

Certificate of Analysis

Third Party Tested Freedom Diagnostics
99.63%
Purity · HPLC-UV
Latest BatchLC-MS IdentityUS Tested
Passed QC panel
Lot BPC10-001Tested Jul 27, 2026
Purity (HPLC-UV)99.63%
Net Peptide Content11.86mg
Identity (LC-MS)BPC-157
Endotoxin (USP <85>)Pass · ≤0.05 EU/mL
Freedom Diagnostics · Independent third-party lab View full COA

Compound Information

Technical specifications
Molecular Profile

What is BPC-157?

TypePentadecapeptide
CAS Number137525-51-0
Molecular Weight1,419.5 g/mol
Amino Acids15
SequenceGEPPPGKPADDAGLV
PubChem Database BPC-157 Research Guide
Storage Requirements

Stability Information

Avoid freeze/thaw cyclesProtect from lightKeep refrigerated
Lyophilized (powder)
−20°C · 24+ months
Reconstituted
2–8°C · ~30 days

Research Background

For laboratory research use only

What BPC-157 is

BPC-157 is a synthetic peptide of fifteen amino acids (sequence GEPPPGKPADDAGLV, molecular weight 1,419.5 g/mol). The sequence corresponds to a fragment of a larger protein first described in gastric juice, which is where the name comes from: "body protection compound". The fragment itself is not known to occur on its own in nature. Every vial of BPC-157 in research circulation is made by solid-phase peptide synthesis, then purified and freeze-dried.

It is one of the most heavily published research peptides. The literature runs to several hundred papers, the large majority of them in rodent models or cell culture and a large share from a single research group at the University of Zagreb. That concentration matters when weighing the evidence, and a careful reader should treat it as a preclinical body of work that still awaits broad independent replication.

What the preclinical literature has examined

Published animal and in vitro studies have looked at BPC-157 in several settings:

  • Tendon and ligament models. Rat studies of transected Achilles tendon and medial collateral ligament, alongside cell-culture work on tendon fibroblast outgrowth and migration and the FAK-paxillin signalling pathway.
  • Angiogenesis. Reports of increased vessel formation in assay systems, with one line of work describing upregulation of VEGFR2 and downstream Akt-eNOS signalling in endothelial cells.
  • Gastrointestinal models. Rodent models of gastric and intestinal lesions, which is the context the peptide was first studied in.
  • Nitric oxide system. Experiments examining how the peptide's effects change in the presence of NO-synthase inhibitors or NO precursors.

None of this establishes safety or efficacy in people. BPC-157 is not an approved drug in any jurisdiction, has no completed large-scale clinical trials, and appears on the World Anti-Doping Agency Prohibited List. Our BPC-157 research guide goes through the published literature and its limits in more detail.

How this material is characterised

The Certificate of Analysis above reports four things for the current lot, each answering a different question:

  • Purity by HPLC-UV is the share of the peptide signal that is the target sequence, as opposed to truncated or modified synthesis by-products.
  • Identity by LC-MS confirms that the main peak has the molecular mass of BPC-157. Purity alone cannot tell you that; a very pure sample of the wrong peptide still scores well on HPLC.
  • Net peptide content is the mass of actual peptide in the vial. Lyophilised peptide always carries counter-ions and residual moisture, so this is the figure to use when calculating concentrations.
  • Endotoxin matters for cell-culture work in particular, where bacterial endotoxin can produce a response that is easily mistaken for an effect of the peptide.

If any of those terms are unfamiliar, how to read a Certificate of Analysis and HPLC vs mass spectrometry explain them from first principles.

Handling in the laboratory

BPC-157 is supplied as a lyophilised powder and is most stable in that form: keep it frozen, dry and away from light. Once reconstituted it should be refrigerated and used within weeks rather than months, and repeated freeze-thaw cycles should be avoided by dividing the solution into single-use aliquots. The sequence contains no cysteine, methionine or tryptophan, so it is less prone to oxidation than many peptides, but its two aspartic acid residues make it sensitive to prolonged exposure to acidic or warm solution. See peptide storage and stability and how to reconstitute a research peptide for procedure and concentration math.

Common questions

Is BPC-157 approved for human use?

No. BPC-157 is not approved by the FDA or any other regulator as a drug, supplement or food ingredient. This material is sold strictly for in vitro and laboratory research and is not for human or veterinary use.

Is BPC-157 a natural peptide?

No. Its sequence corresponds to a fragment of a protein described in gastric juice, but the 15-amino-acid fragment is not known to occur on its own in nature. All research material is produced by solid-phase peptide synthesis.

What is the molecular weight and sequence of BPC-157?

BPC-157 is a pentadecapeptide with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV), a molecular weight of 1,419.5 g/mol and CAS number 137525-51-0.

Why does the vial contain a different mass than the label amount?

The label states the nominal fill. Net peptide content on the Certificate of Analysis is the measured mass of peptide in the vial for that lot, after accounting for counter-ions and residual moisture, and is the figure to use for concentration calculations.

How should lyophilised BPC-157 be stored?

Keep the lyophilised powder at -20 C, dry and protected from light. After reconstitution, store at 2-8 C, avoid repeated freeze-thaw cycles, and aliquot into single-use volumes where the protocol allows.

Frequently Researched Together

Important Research Notice

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

By purchasing, you confirm that you are a qualified researcher and will use these products in accordance with all applicable laws and regulations.